p38 MAP kinase: A convergence point in cancer therapy

Trends in Molecular Medicine

Volumn 10, Issue 3, 2004, Pages 125-129

  Olson, James M ^a   Hallahan, Andrew R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 6 (4 FLUOROPHENYL) 2,3 DIHYDRO 5 (4 PYRIDYL)IMIDAZO[2,1 B]THIAZOLE; ANTINEOPLASTIC AGENT; CISPLATIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NOCODAZOLE; PACLITAXEL; RETINOID; VINBLASTINE; VINCRISTINE;

APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; ENZYME ACTIVATION; HUMAN; REVIEW; SIGNAL TRANSDUCTION;

EID: 1442274808     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.01.007     Document Type: Article

References (46)

1. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
2. Xia Z., et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
3. Galcheva-Gargova Z., et al. An osmosensing signal transduction pathway in mammalian cells. Science. 265:1994;806-808.
4. Zhou G., et al. Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 270:1995;12665-12669.
5. Lee J.D., et al. Primary structure of BMK1: a new mammalian map kinase. Biochem. Biophys. Res. Commun. 213:1995;715-724.
6. Abe M.K., et al. Extracellular signal-regulated kinase 7 (ERK7), a novel ERK with a C-terminal domain that regulates its activity, its cellular localization, and cell growth. Mol. Cell. Biol. 19:1999;1301-1312.
7. Abe M.K., et al. ERK8, a new member of the mitogen-activated protein kinase family. J. Biol. Chem. 277:2002;16733-16743.
8. Zelivianski S., et al. ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. Int. J. Cancer. 107:2003;478-485.
9. Han J., et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808-811.
10. Lee J.C., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739-746.
11. Rouse J., et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 78:1994;1027-1037.
12. Zhang F., et al. Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution. Nature. 367:1994;704-711.
13. Wilson K.P., et al. Crystal structure of p38 mitogen-activated protein kinase. J. Biol. Chem. 271:1996;27696-27700.
14. Barancik M., et al. Okadaic acid and anisomycin are protective and stimulate the SAPK/JNK pathway. J. Cardiovasc. Pharmacol. 34:1999;182-190.
15. Lee T., et al. Role of PP2A in the regulation of p38 MAPK activation in bovine aortic endothelial cells exposed to cyclic strain. J. Cell. Physiol. 194:2003;349-355.
16. Levy-Nissenbaum O., et al. Overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukemia. Cancer Lett. 199:2003;185-192.
17. Enslen H., et al. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273:1998;1741-1748.
18. Eckert R.L., et al. p38 mitogen-activated protein kinases on the body surface - a function for p38δ J. Invest. Dermatol. 120:2003;823-828.
19. Raingeaud J., et al. MKK3- and MKK6- regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1996;1247-1255.
20. Wang X.Z., Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science. 272:1996;1347-1349.
21. Han J., et al. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature. 386:1997;296-299.
22. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:2002;1911-1912.
23. van der Houven van Oordt W., et al. The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J. Cell Biol. 149:2000;307-316.
24. Bulavin D.V., et al. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 18:1999;6845-6854.
25. Hildesheim J., et al. Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res. 62:2002;7305-7315.
26. Sanchez-Prieto R., et al. Regulation of p73 by c-Abl through the p38 MAP kinase pathway. Oncogene. 21:2002;974-979.
27. Kumar S., et al. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2:2003;717-726.
28. Lee J.C., et al. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann. New York Acad. Sci. 696:1993;149-170.
29. Lee J.C., et al. p38 mitogen-activated protein kinase inhibitors - mechanisms and therapeutic potentials. Pharmacol. Ther. 82:1999;389-397.
30. Hallahan A.R., et al. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat. Med. 9:2003;1033-1038.
31. Holmes W.F., et al. Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway. Oncogene. 22:2003;6377-6386.
32. Deacon K., et al. p38 mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest. Mol. Biol. Cell. 14:2003;2071-2087.
33. Losa J.H., et al. Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene. 22:2003;3998-4006.
34. Park M.T., et al. Suppression of extracellular signal-related kinase and activation of p38 mitogen-activated protein kinase are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. J. Biol. Chem. 278:2003;50624- 50634.
35. Shimada K., et al. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis. 24:2003;1067-1075.
36. Weijzen S., et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat. Med. 8:2002;979-986.
37. Kim M.S., et al. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 63:2003;5454-5461.
38. Horowitz J.C., et al. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor β1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J. Biol. Chem. 279:2004;1359-1367.
39. Gianni M., et al. Down-regulation of the phosphatidylinositol 3-kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional activity of retinoic acid receptor γ2. J. Biol. Chem. 277:2002;24859-24862.
40. Puri P.L., et al. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 14:2000;574-584.
41. Iyoda K., et al. Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer. 97:2003;3017-3026.
42. Shou Y., et al. p38 mitogen-activated protein kinase regulates Bax translocation in cyanide-induced apoptosis. Toxicol. Sci. 75:2003;99-107.
43. Yilmaz A., et al. p38 MAPK inhibition is critically involved in VEGFR-2-mediated endothelial cell survival. Biochem. Biophys. Res. Commun. 306:2003;730-736.
44. Jung Y.D., et al. Vascular endothelial growth factor is upregulated by interleukin-1β in human vascular smooth muscle cells via the p38 mitogen-activated protein kinase pathway. Angiogenesis. 4:2001;155-162.
45. McMullen M., et al. Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2. Oncogene. 2004;. doi:10.1038/sj.onc.1207243.
46. Issbrucker K., et al. p38 MAP kinase - a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J. 17:2003;262-264.